UK NSC publishes SMA screening evidence documents
The UK NSC has published a suite of documents relating to the review of evidence on newborn screening for spinal muscular atrophy.
Newborn Blood Spot Screening
UK NSC consults on extending the in-service evaluation of screening for SCID
Posted by:
Mike Harris, Posted on:
-
Categories:
Newborn Blood Spot Screening, UK National Screening Committee
The UK National Screening Committee has opened a consultation on a recommendation to continue the in-service evaluation of newborn screening for SCID in NHS services.
SMA Screening ISE partnership board updated on NIHR research call
The National Institute for Health and Care Research has advertised the research call for the in-service evaluation of newborn screening for spinal muscular atrophy.
SMA Screening ISE Partnership Board update February 2025
An update from the partnership board that is overseeing the planning of an in-service evaluation (ISE) of newborn screening for spinal muscular atrophy.
SMA ISE partnership board updated on very useful modelling study workshop
The latest meeting of the SMA Screening In-service evaluation Partnership Board heard that interim results of a new modelling study into SMA screening for the UK context had been presented to a stakeholder workshop.
Progress update on UK NSC’s recommendation to screen for tyrosinaemia
Oversight group gets to work in following up UK NSC’s recommendation for the implementation of newborn screening for Hereditary Tyrosinaemia Type 1.
Changes ahead for the national screening system
Posted by:
Nick Johnstone-Waddell, Posted on:
-
Categories:
Abdominal Aortic Aneurysm Screening, Bowel Cancer Screening, Breast Screening, Cervical Screening, Diabetic Eye Screening, Fetal Anomaly Screening, General, Infectious Diseases in Pregnancy Screening, Newborn and Infant Physical Examination, Newborn Blood Spot Screening, Newborn Hearing Screening, Sickle Cell and Thalassaemia Screening, UK National Screening Committee
Details of changes to the national screening system from 1 October, due to the closure of Public Health England.
New start date for NHS SCID screening evaluation in England
Posted by:
Christine Cavanagh, Posted on:
-
Categories:
Newborn Blood Spot Screening, UK National Screening Committee
The NHS severe combined immunodeficiency (SCID) screening evaluation in England is scheduled to start from September 2021.
New format to UK NSC consultations starts with 5 newborn blood spot conditions
Posted by:
John Marshall, Posted on:
-
Categories:
General, Newborn Blood Spot Screening, UK National Screening Committee
In 2016 the UK National Screening Committee (UK NSC) was piloting a new approach for reviewing existing screening programmes.
2015: an exciting year for screening
Posted by:
Nick Johnstone-Waddell, Posted on:
-
Categories:
Fetal Anomaly Screening, General, Newborn Blood Spot Screening, UK National Screening Committee
Professor Anne Mackie reflects on 2015 calling it 'a particularly exciting year for screening'.